440 related articles for article (PubMed ID: 27865852)
1. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing.
Liu J; Shui SL
J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852
[TBL] [Abstract][Full Text] [Related]
2. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
5. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
6. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of CRISPR RNA-guided genome editing.
Koo T; Kim JS
Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic gene editing: delivery and regulatory perspectives.
Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
10. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
12. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
13. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
14. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
Li Y; Song YH; Liu B; Yu XY
Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
16. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
17. Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ates I; Rathbone T; Stuart C; Bridges PH; Cottle RN
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32977396
[TBL] [Abstract][Full Text] [Related]
18. Retroviral Vectors for Cancer Gene Therapy.
Schambach A; Morgan M
Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
[TBL] [Abstract][Full Text] [Related]
19. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
March OP; Reichelt J; Koller U
Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
[TBL] [Abstract][Full Text] [Related]
20. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]